Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Skin Neoplasms 3Kasabach-Merritt Syndrome 2Kaposiform Hemangioendothelioma 2Waldenstrom Macroglobulinemia 1Renal Transplant Patients at High-risk for Skin Cancer 1Refractory Solid Tumors 1Peutz-Jeghers Syndrome 1Neoplasms, Plasma Cell 1Lymphoma 1Leukemia, Lymphocytic, Chronic, B-Cell 1Leiomyoma 1Hereditary Sensory and Autonomic Neuropathies 1Hemangioma 1Angiomyolipoma 1

Interventions

Steroids 1Sirolimus 1Propranolol 1Prednisolone 1Adrenergic beta-Antagonists 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 4 × Hemangioma × Sirolimus × Clear all
NCT04077515 2023-01-30

Safety and Efficacy of Low-dose Sirolimus to Kaposiform Hemangioendothelioma

Children's Hospital of Fudan University

Phase 4 Completed
92 enrolled

Kaposiform Hemangioendothelioma, Hemangioma, Kasabach-Merritt Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon âš¡